Valuentum Exclusive Analysis for the Discerning Investor

Symbol Keyword

Member Login Email Password Join Now Forgotten Password Newsletters/Portfolios View Current and Archived Dividend Growth Newsletters View Current and Archived Best Ideas Newsletters Valuentum's Dividend Growth Newsletter Portfolio Valuentum's Best Ideas Newsletter Portfolio Order the Exclusive Publication! View Current and Archived Exclusive Editions Order the High Yield Dividend Newsletter! Dividend Cushion Efficacy Calculation Dividend-Adjusted Leverage White Paper Stock Screens How to Filter Data in Microsoft Excel Like a Pro Download Weekly Stock Screener (xls) -- login required The Quarterly DataScreener Products & Tools Financial Advisor (GOLD LEVEL) Publications DCF Valuation Model Template Order Value Trap Order Value Trap, second edition Value Trap Order PDF Copy Order Paperback Copy Presentation BookLife Review BlueInk Review Foreword Review Readers' Favorite Review Axiom Bronze Praise The Buying Index, VBI Value and Momentum Within Stocks, Too (2017) The Case for the Valuentum Style of Investing (2012) Investing's Odd Couple: Value and Momentum (2013) Stock-Selection Methodology, the Valuentum Buying Index (2011) Why Valuentum Buying Index Ratings Matter (2014) Dividend Changes Dividend Increases/Decreases for the Week of July 25 Dividend Increases/Decreases for the Week of July 18 Dividend Increases/Decreases for the Week of July 11 Dividend Increases/Decreases for the Week of July 4 Dividend Increases/Decreases for the Week of June 27 Dividend Increases/Decreases for the Week of June 20

Results 21 - 30 of 135 for mye. (0.29 seconds) AstraZeneca Is Not Immune to Patent Cliff AstraZeneca faced revenue and earnings pressure from the... Valuentum's November Edition of Its Dividend Growth Newsletter! The November edition of our Dividend Growth Newsletter is... Johnson & Johnson’s Patent Expiration Profile Is Fantastic The dividend growth giant continues to impress. Inside AbbVie: A Look at a New Pharmaceutical Giant Let's take a look at Abbott's new standalone business,... What a Month! Valuentum's February Edition of Its Dividend Growth Newsletter! The February edition of our Dividend Growth Newsletter is... Firms Raising Their Dividends in the Week Ending March 8 This week, a plethora of firms raised their dividends. Looking for a Pullback to Pick Up Johnson & Johnson's Shares We think J&J's shares are fully-valued at this time,... Generic Pharmaceuticals: Patent Expiration and Low Global Utilization Rates Create Opportunities Big Pharma is not dead, but neither are the generics.... Which Sectors Are Leading the Market Higher? And Why Is This Important? Identifying sector and industry leadership is very... National Oilwell Varco Posts Record Second Quarter Results Soft Canadian demand wasn’t enough to offset... prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | next